SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-000908
Filing Date
2023-01-09
Accepted
2023-01-09 08:32:40
Documents
15
Period of Report
2023-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41137
2 ex99-1.htm EX-99.1 13767
3 ex99-1_001.jpg GRAPHIC 3790
  Complete submission text file 0001493152-23-000908.txt   282894

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bfri-20230109.xsd EX-101.SCH 3750
5 XBRL DEFINITION FILE bfri-20230109_def.xml EX-101.DEF 26643
6 XBRL LABEL FILE bfri-20230109_lab.xml EX-101.LAB 36707
7 XBRL PRESENTATION FILE bfri-20230109_pre.xml EX-101.PRE 25268
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4688
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 23516756
SIC: 2834 Pharmaceutical Preparations